Introduction to survival analysis in practice
F Emmert-Streib, M Dehmer - Machine Learning and Knowledge …, 2019 - mdpi.com
The modeling of time to event data is an important topic with many applications in diverse
areas. The collective of methods to analyze such data are called survival analysis, event …
areas. The collective of methods to analyze such data are called survival analysis, event …
NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer
KA Gaptulbarova, MM Tsyganov… - Experimental …, 2020 - exp-oncology.com.ua
The NF-kB1 gene belongs to the family of transcription factors that are involved in the
regulation of a wide range of biological reactions. It has been established that NF-kB1 plays …
regulation of a wide range of biological reactions. It has been established that NF-kB1 plays …
The BRCA1/BARD1 ubiquitin ligase and its substrates
SR Witus, MD Stewart, RE Klevit - Biochemical Journal, 2021 - portlandpress.com
Mutations in breast cancer type 1 susceptibility protein (BRCA1) and its heterodimeric
binding partner BARD1 confer a high risk for the development of breast and ovarian …
binding partner BARD1 confer a high risk for the development of breast and ovarian …
[HTML][HTML] Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode
SA Vlahopoulos - Cancer biology & medicine, 2017 - ncbi.nlm.nih.gov
The role of the transcription factor NF-κB in shaping the cancer microenvironment is
becoming increasingly clear. Inflammation alters the activity of enzymes that modulate NF …
becoming increasingly clear. Inflammation alters the activity of enzymes that modulate NF …
Automated tumour recognition and digital pathology scoring unravels new role for PD‐L1 in predicting good outcome in ER‐/HER2+ breast cancer
MP Humphries, S Hynes, V Bingham… - Journal of …, 2018 - Wiley Online Library
The role of PD‐L1 as a prognostic and predictive biomarker is an area of great interest.
However, there is a lack of consensus on how to deliver PD‐L1 as a clinical biomarker. At …
However, there is a lack of consensus on how to deliver PD‐L1 as a clinical biomarker. At …
Dual mechanisms of LYN kinase dysregulation drive aggressive behavior in breast cancer cells
G Tornillo, C Knowlson, H Kendrick, J Cooke, H Mirza… - Cell reports, 2018 - cell.com
The SRC-family kinase LYN is highly expressed in triple-negative/basal-like breast cancer
(TNBC) and in the cell of origin of these tumors, c-KIT-positive luminal progenitors. Here, we …
(TNBC) and in the cell of origin of these tumors, c-KIT-positive luminal progenitors. Here, we …
[图书][B] Elements of Data Science, Machine Learning, and Artificial Intelligence Using R
The digitalization of all areas of science, industry, and society has led to an unprecedented
flood of data. However, after the initial enthusiasm for the anticipated wealth of information …
flood of data. However, after the initial enthusiasm for the anticipated wealth of information …
Out-RANKing BRCA1 in mutation carriers
E Nolan, GJ Lindeman, JE Visvader - Cancer research, 2017 - AACR
Beyond prophylactic mastectomy, there are currently very few options available to BRCA1
mutation carriers to help reduce their risk of developing breast cancer. An effective …
mutation carriers to help reduce their risk of developing breast cancer. An effective …
A novel role for cathepsin S as a potential biomarker in triple negative breast cancer
RDA Wilkinson, RE Burden, SH McDowell… - Journal of …, 2019 - Wiley Online Library
Cathepsin S (CTSS) has previously been implicated in a number of cancer types, where it is
associated with poor clinical features and outcome. To date, patient outcome in breast …
associated with poor clinical features and outcome. To date, patient outcome in breast …
Drug repurposing for Basal breast cancer subpopulations using modular network signatures
H Coria-Rodríguez, S Ochoa… - … Biology and Chemistry, 2023 - Elsevier
Breast cancer is characterized as being a heterogeneous pathology with a broad phenotype
variability. Breast cancer subtypes have been developed in order to capture some of this …
variability. Breast cancer subtypes have been developed in order to capture some of this …